Granulysin Antibody (B-L38) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-18104
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # B-L38
Format
Azide and BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Recombinant human Granulysin (NKG5 and LAG-2). Hybridoma: Myeloma X63/AG.8653 x Balb/c node cells
Specificity
Recognizes both natural and recombinant human Granulysin
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Scientific Data Images for Granulysin Antibody (B-L38) - Azide and BSA Free
Flow Cytometry: Granulysin Antibody (B-L38) - Azide and BSA Free [NBP3-18104]
Flow Cytometry: Granulysin Antibody (B-L38) - Azide and BSA Free [NBP3-18104] - A typical staining pattern with the B-L38 monoclonal antibody of activated NK.Applications for Granulysin Antibody (B-L38) - Azide and BSA Free
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS. Sterile-filtered through 0.22 um.
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -70C long term. Avoid freeze-thaw cycles.
Background: Granulysin
Alternate Names
GNLY, LAG2, Lymphokine, NKG5, TLA519
Gene Symbol
GNLY
Additional Granulysin Products
Product Documents for Granulysin Antibody (B-L38) - Azide and BSA Free
Product Specific Notices for Granulysin Antibody (B-L38) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...